Home > Research Areas > Infection > Influenza
Cat. No. Product name CAS No.
DC11056 Baloxavir marboxil Featured

Baloxavir marboxil is a prodrug of S-033447. S-033447 is a small molecule inhibitor of the cap-dependent endonuclease of influenza A and B viruses.

1985606-14-1
DC9486 Nucleozin Featured

Nucleozin targets influenza A nucleoprotein (NP), a multifunctional, RNA-binding protein necessary for virus replication.

341001-38-5
DCAPI1594 Oseltamivir phosphate Featured

OSELTAMIVIR is an active (orally) inhibitor of the influenze virus neuraminidase and converted to the active acid metabolite in vivo.

204255-11-8
DCAPI1121 Peramivir

Peramivir

229614-55-5
DCAPI1010 Peramivir Trihydrate Featured

Peramivir, also known as BCX1812 and RWJ 270201, is an antiviral drug for the treatment of influenza. Peramivir is a neuraminidase inhibitor, acting as a transition-state analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. Peramivir was approved to treat influenza infection in adults.

1041434-82-5
DC9815 Pimodivir(VX-787) Featured

Pimodivir(VX-787) is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. 

1629869-44-8
DC5105 Favipiravir (T-705) Featured

T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.T 705(Favipiravir) is useful for Antiviral agents.

259793-96-9
DC8429 Verdinexor (KPT-335) Featured

Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor.

1392136-43-4
DCAPI1063 Zanamivir (Relenza) Featured

Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively.

139110-80-8
<PrevNext >